• 0 Items - £0.00
    • No products in the cart.

From £33.99

No More Pandemics

Toward a World Free from Infectious Diseases
By: Hiroshi Kase, Yoshikazu G. Mikawa

From £33.99

This book proposes a path to end pandemics and achieve a world without infectious diseases. Using today’s science, it is entirely possible to avoid infection by implementing an air ventilation approach to stop viruses from entering the body. The challenge must be confronted now.

This book proposes a concrete path to bring an end to pandemics and achieve a world without infectious diseases, suggesting an escape from the long…
From £33.99
From £33.99
Share

This book proposes a concrete path to bring an end to pandemics and achieve a world without infectious diseases, suggesting an escape from the long history of infectious diseases that have brought misery and confusion to humanity. The book presents an Mikawa-Kase-AQIP model to illuminate the generation of infection units originating from the lungs, where viral proliferation occurs. It further elucidates the theoretical distribution of viruses entrapped within aerosol particles.
It is entirely possible to avoid infection using today’s science and technology, if we all understand, share, and implement an air ventilation approach which will stop viruses from entering the body. The challenge to eradicate future pandemics must be confronted now. The aim in this book is to present the answer.

Hiroshi Kase, PhD, joined Kyowa Hakko Kogyo Co., Ltd. (Japan) in 1966, and served as researcher, as Director of the Pharmaceutical Research Institute and as Global Project Leader. As a representative accomplishment, he was involved in the discovery and development of adenosine A2A antagonist KW-6002 (istradefylline) for a new Parkinson’s Disease drug with a novel action mechanism, leading to success in its launch in Japan and the United States. He is the author and editor of “Adenosine Receptor and Parkinson’s Disease” (2000).

Yoshikazu G. Mikawa, MD, PhD joined Dr Sydney Brenner’s Molecular Genetics Unit in Cambridge, UK, in 1989 and collaborated in the USA until 2005. His work propelled DNA technologies, particularly in the next-generation sequencing. He developed a bacteriophage lambda peptide display system and genetically modified bacteria for ligand-receptor binding analysis. He was Principal Scientific Officer at Population Genetics Technologies Ltd, UK (2005-2013). He co-founded Nemesis Bioscience Ltd (UK) in 2014, focusing on cutting-edge technologies addressing antimicrobial resistance.

Hardback

  • ISBN: 1-0364-0307-6
  • ISBN13: 978-1-0364-0307-2
  • Date of Publication: 2024-04-17

Paperback

  • ISBN: 1-0364-4136-9
  • ISBN13: 978-1-0364-4136-4
  • Date of Publication: 2025-01-13

Ebook

  • ISBN: 1-0364-0308-4
  • ISBN13: 978-1-0364-0308-9
  • Date of Publication: 2025-01-13

Subject Codes:

  • BIC: MJCJ, TQ, PBWH
  • THEMA: MJCJ, TQ, PBWH
178
  • “It reads very well; I think the central message is strongly given, that we should reduce the risk of pandemics through monitoring and maintaining the indoor air quality. I would be happy to recommend this book to everybody, whether they are students, homeowners, teachers, architects, building managers, or even UN/WHO technocrats.”
    - Peter Richardson Vice President of Pharmacology at Benevolent AI, UK
  • “This book provides a new outlook on avoiding the pandemics which have plagued mankind over the millennia.”
    - Peter Jenner Emeritus Professor of Pharmacology, King’s College London, UK
  • “This seems to be a most impressive piece of work – the quantification, rigour and consistency of the arguments and data give it real power!”
    - Robin Irvine Emeritus Royal Society Research Professor of Molecular Pharmacology at the University of Cambridge, UK

Meet The Author